Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed. Medscape Medical News
Log in met Medi-Access
Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen
Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
Medscape: Urology | Geplaatst op 15.05.2022 15:24